Halmos B - Search Results

1

Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung Cancer.

Halmos B, Pennell NA, Fu P, Saad S, Gadgeel S, Otterson GA, Mekhail T, Snell M, Kuebler JP, Sharma N, Dowlati A. Halmos B, et al. Oncologist. 2015 Nov;20(11):1298-303. doi: 10.1634/theoncologist.2015-0136. Epub 2015 Aug 25. Oncologist. 2015. PMID: 26306902 Free PMC article. Clinical Trial.

2

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

Kobayashi S, Boggon TJ, Dayaram T, Jänne PA, Kocher O, Meyerson M, Johnson BE, Eck MJ, Tenen DG, Halmos B. Kobayashi S, et al. Among authors: halmos b. N Engl J Med. 2005 Feb 24;352(8):786-92. doi: 10.1056/NEJMoa044238. N Engl J Med. 2005. PMID: 15728811 Free article.

3

Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib.

Jackman DM, Yeap BY, Sequist LV, Lindeman N, Holmes AJ, Joshi VA, Bell DW, Huberman MS, Halmos B, Rabin MS, Haber DA, Lynch TJ, Meyerson M, Johnson BE, Jänne PA. Jackman DM, et al. Among authors: halmos b. Clin Cancer Res. 2006 Jul 1;12(13):3908-14. doi: 10.1158/1078-0432.CCR-06-0462. Clin Cancer Res. 2006. PMID: 16818686

4

Resistance to an irreversible epidermal growth factor receptor (EGFR) inhibitor in EGFR-mutant lung cancer reveals novel treatment strategies.

Yu Z, Boggon TJ, Kobayashi S, Jin C, Ma PC, Dowlati A, Kern JA, Tenen DG, Halmos B. Yu Z, et al. Among authors: halmos b. Cancer Res. 2007 Nov 1;67(21):10417-27. doi: 10.1158/0008-5472.CAN-07-1248. Cancer Res. 2007. PMID: 17974985

5

SCH66336, inhibitor of protein farnesylation, blocks signal transducer and activators of transcription 3 signaling in lung cancer and interacts with a small molecule inhibitor of epidermal growth factor receptor/human epidermal growth factor receptor 2.

Dowlati A, Kluge A, Nethery D, Halmos B, Kern JA. Dowlati A, et al. Among authors: halmos b. Anticancer Drugs. 2008 Jan;19(1):9-16. doi: 10.1097/CAD.0b013e3282f1a908. Anticancer Drugs. 2008. PMID: 18043125

6

15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancer.

Huang G, Eisenberg R, Yan M, Monti S, Lawrence E, Fu P, Walbroehl J, Löwenberg E, Golub T, Merchan J, Tenen DG, Markowitz SD, Halmos B. Huang G, et al. Among authors: halmos b. Cancer Res. 2008 Jul 1;68(13):5040-8. doi: 10.1158/0008-5472.CAN-07-6575. Cancer Res. 2008. PMID: 18593902 Free PMC article.

7

Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer.

Tang Z, Du R, Jiang S, Wu C, Barkauskas DS, Richey J, Molter J, Lam M, Flask C, Gerson S, Dowlati A, Liu L, Lee Z, Halmos B, Wang Y, Kern JA, Ma PC. Tang Z, et al. Among authors: halmos b. Br J Cancer. 2008 Sep 16;99(6):911-22. doi: 10.1038/sj.bjc.6604559. Br J Cancer. 2008. PMID: 19238632 Free PMC article.

8

Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer.

Kluge A, Dabir S, Kern J, Nethery D, Halmos B, Ma P, Dowlati A. Kluge A, et al. Among authors: halmos b. Int J Cancer. 2009 Oct 1;125(7):1728-34. doi: 10.1002/ijc.24553. Int J Cancer. 2009. PMID: 19569236 Free PMC article.

9

A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer.

Lynch TJ, Fenton D, Hirsh V, Bodkin D, Middleman EL, Chiappori A, Halmos B, Favis R, Liu H, Trepicchio WL, Eton O, Shepherd FA. Lynch TJ, et al. Among authors: halmos b. J Thorac Oncol. 2009 Aug;4(8):1002-9. doi: 10.1097/JTO.0b013e3181aba89f. J Thorac Oncol. 2009. PMID: 19633475 Free article. Clinical Trial.

10

Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer.

Leidner RS, Fu P, Clifford B, Hamdan A, Jin C, Eisenberg R, Boggon TJ, Skokan M, Franklin WA, Cappuzzo F, Hirsch FR, Varella-Garcia M, Halmos B. Leidner RS, et al. Among authors: halmos b. J Clin Oncol. 2009 Nov 20;27(33):5620-6. doi: 10.1200/JCO.2009.23.1431. Epub 2009 Sep 28. J Clin Oncol. 2009. PMID: 19786660 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters